As a proof-of-concept, glutathione (GSH)-triggered release (to mimic the redox tumor microenvironment) was investigated in vitro from Ms, R-Ms, PR-Ms, and PT-R-Ms formulations (without GSH) and from PT-R-Ms in the presence of 20 mM GSH. Here, F2 is linked to neoplasm.